glaxosmithkline pharma gmbh
Trade trend analysis
Mon
|
Year
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for glaxosmithkline pharma gmbh from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 56 transactions, with a transaction quantity of 4975427.14 and a transaction weight of 0.
- Year Transactions Quantity Weight
- 2025 412 23229827.81 0
- 2026 56 4975427.14 0
Bill of lading data
< 1/15 >- Trade date 2026/02/27 B/L No. 2080512
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline pharma gmbh
- POLs —— PODs delhi
- Supply area England Purchas area India
- Weight —— Amount 177.93
- Hs code 30021290 Product tags ting,antiserum,influenza,cd
- Product description INFLUENZA ANTISERUM SAMPLES FOC NCV ONLY FOR TESTING PURPOSE AT CDTLINFLUENZA ANTISERUM SAMPLES FOC NCV ONLY FOR TESTING PURPO Expand
- Trade date 2026/02/27 B/L No. 3344350
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline pharma gmbh
- POLs —— PODs mumbai (ex bombay)
- Supply area Belgium Purchas area India
- Weight —— Amount 504397.44
- Hs code 30024119 Product tags vaccine,jug,flor,bed,synflorix,pac sy,polysaccharide,occa,neumo
- Product description SYNFLORIX VACCINE PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE ADSORBED I P LIST 2 SR NO 80 PAC SYNFLORIX VACCINE PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VA Expand
- Trade date 2026/02/27 B/L No. 4305174
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline pharma gmbh
- POLs —— PODs delhi
- Supply area England Purchas area India
- Weight —— Amount 177.93
- Hs code 30021290 Product tags ting,antigen,cd,influenza,seat
- Product description INFLUENZA ANTIGEN SAMPLES FOC NCV ONLY FOR TESTING PURPOSEAT CDTLINFLUENZA ANTIGEN SAMPLES FOC NCV ONLY FOR TESTING PURPOSE Expand
- Trade date 2026/02/25 B/L No. 0622307
- Suppliers nanjing well pharmaceutical group Buyers glaxosmithkline pharma gmbh
- POLs —— PODs jawaharlal nehru (nhava sheva)
- Supply area China Purchas area India
- Weight —— Amount 6300
- Hs code 39072910 Product tags polyethylene,glycol 3350
- Product description POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 3350 Expand
- Trade date 2026/02/25 B/L No. 1377405
- Suppliers nanjing well pharmaceutical group Buyers glaxosmithkline pharma gmbh
- POLs —— PODs jawaharlal nehru (nhava sheva)
- Supply area China Purchas area India
- Weight —— Amount 14204.8
- Hs code 39072910 Product tags polyethylene glycol
- Product description POLYETHYLENE GLYCOL 400 POLYETHYLENE GLYCOL 400 Expand
- Trade date 2026/02/25 B/L No. 3370617
- Suppliers symbiotic speciality ingredients sdn bhd Buyers glaxosmithkline pharma gmbh
- POLs —— PODs mumbai (ex bombay)
- Supply area Malaysia Purchas area India
- Weight —— Amount 63900
- Hs code 29372200 Product tags betamethasone sodium phosphate
- Product description BETAMETHASONE SODIUM PHOSPHATE IP BETAMETHASONE SODIUM PHOSPHATE IP Expand
- Trade date 2026/02/25 B/L No. 2718011
- Suppliers nanjing well pharmaceutical group Buyers glaxosmithkline pharma gmbh
- POLs —— PODs jawaharlal nehru (nhava sheva)
- Supply area China Purchas area India
- Weight —— Amount 10500
- Hs code 39072910 Product tags polyethylene,glycol 3350
- Product description POLYETHYLENE GLYCOL 3350 POLYETHYLENE GLYCOL 3350 Expand
- Trade date 2026/02/24 B/L No. 0816282
- Suppliers mdnf Buyers glaxosmithkline pharma gmbh
- POLs —— PODs jawaharlal nehru (nhava sheva)
- Supply area Italy Purchas area India
- Weight —— Amount 5906.31
- Hs code 30042019 Product tags pace,injection,cefuroxime sodium,india
- Product description SUPACEF 250MG 17ML TP X1 INDIA CEFUROXIME SODIUM INJECTIONIP 250MG SUPACEF 250MG 17ML TP X1 INDIA CEFUROXIME SODIUM INJECTION Expand
- Trade date 2026/02/24 B/L No. 3565722
- Suppliers gsk trading servicee ltd. Buyers glaxosmithkline pharma gmbh
- POLs —— PODs jawaharlal nehru (nhava sheva)
- Supply area England Purchas area India
- Weight —— Amount 170890.99
- Hs code 30043200 Product tags inhalation,fluticasone,iu,vilanterol,lip,powder,furo
- Product description TRELEGY ELLIPTA 100 62 5 25MCG FLUTICASONE FUROATE UMEDIDINIUM AND VILANTEROL POWDER FOR INHALATION LIST 2 SR 87 TRELEGY ELLIPTA 100 62 5 25MCG FLUTICASONE FUROATE UMEDIDI Expand
- Trade date 2026/02/24 B/L No. 6026373
- Suppliers mdnf Buyers glaxosmithkline pharma gmbh
- POLs —— PODs jawaharlal nehru (nhava sheva)
- Supply area Italy Purchas area India
- Weight —— Amount 79657.33
- Hs code 30042019 Product tags p 75,pace,injection,cefuroxime sodium,india
- Product description SUPACEF 750MG 17ML TP X1 INDIA CEFUROXIME SODIUM INJECTIONIP 750MG SUPACEF 750MG 17ML TP X1 INDIA CEFUROXIME SODIUM INJECTION Expand
- Trade date 2026/02/21 B/L No. 4730831
- Suppliers united states pharmacopeial convention Buyers glaxosmithkline pharma gmbh
- POLs —— PODs mumbai (ex bombay)
- Supply area China Purchas area India
- Weight —— Amount 9632.16
- Hs code 29419090 Product tags reference standard,mupirocin,ear,lithium,laboratory
- Product description MUPIROCIN LITHIUM 100 MG 73346 79 9 R19710 EAR99 USP REFERENCE STANDARDS FOR LABORATORY USE ONLY MUPIROCIN LITHIUM 100 MG 73346 79 9 R19710 EAR99 USP REFE Expand
- Trade date 2026/02/20 B/L No. 4387668
- Suppliers zhejiang charioteer pharmaceutical co.ltd zhejiang charioteer pharmaceutical co.ltd. Buyers glaxosmithkline pharma gmbh
- POLs —— PODs jawaharlal nehru (nhava sheva)
- Supply area China Purchas area India
- Weight —— Amount 51700
- Hs code 29335990 Product tags acyclovir
- Product description ACYCLOVIR IP ACYCLOVIR IP Expand
- Trade date 2026/02/20 B/L No. 3401148
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline pharma gmbh
- POLs —— PODs mumbai (ex bombay)
- Supply area Belgium Purchas area India
- Weight —— Amount 542039.04
- Hs code 30024119 Product tags vaccine,jug,flor,bed,synflorix,pac sy,polysaccharide,occa,neumo
- Product description SYNFLORIX VACCINE PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE ADSORBED I P LIST 2 SR NO 80 PAC SYNFLORIX VACCINE PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VA Expand
- Trade date 2026/02/19 B/L No. 2521466
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline pharma gmbh
- POLs —— PODs mumbai (ex bombay)
- Supply area Belgium Purchas area India
- Weight —— Amount 1605.73
- Hs code 30021290 Product tags lysi,onia,tand,rain,streptococcus,neu,l 50
- Product description STREPTOCOCCUS PNEUMONIAE STANDARD INTERNAL CONTROL 500UL EACH FOC NCV STRAINS FOR ANALYSIS USESTREPTOCOCCUS PNEUMONIAE STANDARD INTERNAL CONTROL 500UL E Expand
- Trade date 2026/02/19 B/L No. 5867107
- Suppliers glaxosmithkline biologicals s.a. Buyers glaxosmithkline pharma gmbh
- POLs —— PODs mumbai (ex bombay)
- Supply area Belgium Purchas area India
- Weight —— Amount 1605.73
- Hs code 30021290 Product tags lysi,onia,tand,rain,streptococcus,neu
- Product description STREPTOCOCCUS PNEUMONIAE STANDARD INTERNAL CONTROL 1 0UL EACH FOC NCV STRAINS FOR ANALYSIS USESTREPTOCOCCUS PNEUMONIAE STANDARD INTERNAL CONTROL 1 0UL E Expand
Partners
Total 165- Rank Company Transactions Per Detail
- 1 gsk trading servicee ltd. italysupplier,they trade on 2026-02-24 1062 6.66% >
- 2 glaxosmithline biologicals na canadasupplier,they trade on 2024-09-19 597 3.74% >
- 3 q squared solutions llc argentinasupplier,they trade on 2023-06-01 571 3.58% >
- 4 glaxo smithkline united statesbuyer,they trade on 2025-06-06 319 2% >
- 5 glaxosmithkline trading svcs pakistanbuyer,they trade on 2010-04-30 275 1.72% > +View All
Products
Total 524- Products Transactions Per Detail
-
vaccine
141 13.18% > -
clinical trial
122 11.4% > -
import
103 9.63% > -
ion
100 9.35% > -
drum
95 8.88% >
+View All
Hscode rank
Total 494- HSCode Name Transactions Per Detail
- HS 29419090 123 11.5% >
- HS 30024119 85 7.94% >
- HS 29419050 79 7.38% >
- HS 38229010 77 7.2% >
- HS 38229090 70 6.54% > +View All
Trading Area
Total 39- Area Transactions Per Detail
- england 1334 8.37% >
- costa rica 697 4.37% >
- belgium 575 3.61% >
- china 378 2.37% >
- italy 363 2.28% > +View All
Port statistics
Total 55- Port Name Transactions Per Detail
- sahar air cargo acc inbom4 5012 31.43% >
- delhi 754 4.73% >
- nhava sheva 369 2.31% >
- bangalore 342 2.14% >
- charleston 270 1.69% > +View All
glaxosmithkline pharma gmbh is india Buyer&Supplier,
and primarily engages in the import and export business of products such as vaccine，clinical trial，import.
According to the 52wmb.com global trade database, as of 2026-02-27, the company has completed 26121 international trades,
with its main trading regions covering england，costa rica,belgium etc.
The core products include HS29419090，HS30024119，HS29419050 etc,
often transported via sahar air cargo acc inbom4，port delhi, port nhava sheva etc,
and its main trading partners are gsk trading servicee ltd.，glaxosmithline biologicals na，q squared solutions llc.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on glaxosmithkline pharma gmbh is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.
Reference contact info
Email Hunting Tool